WM
51
4
TXT
68
6
VIX
21
-8
PFE
39
-12
FCX
75
3
EMR
71
3
AEE
48
-2
CAG
43
2
FFIV
55
5
ALLE
50
9
CF
48
6
NRG
59
2
KMX
42
-5
INTU
65
3
MOS
40
11
ECL
54
2
ITW
42
2
CCL
68
8
PSA
51
5
WYNN
36
2
WM
51
4
TXT
68
6
VIX
21
-8
PFE
39
-12
FCX
75
3
EMR
71
3
AEE
48
-2
CAG
43
2
FFIV
55
5
ALLE
50
9
CF
48
6
NRG
59
2
KMX
42
-5
INTU
65
3
MOS
40
11
ECL
54
2
ITW
42
2
CCL
68
8
PSA
51
5
WYNN
36
2
Financhill
Back

Aardvark Therapeutics, Inc. 10K Form

Buy
92

AARD
Aardvark Therapeutics, Inc.

Last Price:
$14.43
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AARD News And Ratings

See the #1 stock for the next 7 days that we like better than AARD

AARD Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-18.5M
Price / Cash Flow: 0
Annual Sales: $5.63
Price / Book: 2.78

Profitability

EPS (TTM): -2.24650
Net Income (TTM): $-48.8M
Gross Margin: $-16K
Return on Equity: -43.34%
Return on Assets: -40.71%

Aardvark Therapeutics, Inc. Earnings Forecast

Key Aardvark Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 3 years have been positive in 1 years.

Aardvark Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Current Symbol: AARD
Website: aardvarktherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 12.03
Quick Ratio: 11.77

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AARD Technical Analysis vs Fundamental Analysis

Buy
92
Aardvark Therapeutics, Inc. (AARD) is a Buy

Is Aardvark Therapeutics, Inc. a Buy or a Sell?